{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:07:57Z","timestamp":1789704477343,"version":"4.0.1"},"reference-count":463,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.jaci.2004.06.047","type":"journal-article","created":{"date-parts":[[2004,9,14]],"date-time":"2004-09-14T14:27:57Z","timestamp":1095172077000},"page":"S51-S131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":517,"special_numbering":"S","title":["Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond"],"prefix":"10.1016","volume":"114","author":[{"given":"Angelo","family":"Agostoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emel","family":"Ayg\u00f6ren-P\u00fcrs\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E.","family":"Binkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Blanch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Bork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Bouillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Bucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J","family":"Castaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cicardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Alvin E","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"De Carolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Drouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Duponchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e1lm\u00e1n","family":"F\u00e1y","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9la","family":"Fekete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"F\u00fcst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albrecht","family":"Gr\u00f6ner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Erik Hack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Harmat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Jakenfelds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Juers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lajos","family":"Kalm\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e1l N.","family":"Kaposi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Kar\u00e1di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Kitzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00edmea","family":"Koll\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfhart","family":"Kreuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lakatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary J.","family":"Longhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Lopez-Trascasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Martinez-Saguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Monnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9va","family":"N\u00e9meth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik Waage","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan H.","family":"Nuijens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"O'Grady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Pappalardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Penna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Perricone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Perricone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Rusicke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J","family":"Sp\u00e4th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Szendei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edit","family":"Tak\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Tordai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Truedsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Be\u00e1ta","family":"Visy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Zanichelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Zingale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2004.06.047_bib1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/0003-4819-73-1-55","article-title":"Hereditary angioneurotic edema: report of a large kindred with defect in C'1 esterase inhibitor and review of the literature","volume":"73","author":"Dennehy","year":"1970","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib2","series-title":"The house of the seven gables","author":"Hawthorne","year":"2001"},{"key":"10.1016\/j.jaci.2004.06.047_bib3","first-page":"513","article-title":"On giant urticaria","volume":"22","author":"Milton","year":"1876","journal-title":"Edinburgh Med J"},{"key":"10.1016\/j.jaci.2004.06.047_bib4","first-page":"129","article-title":"\u00dcber akutes umschriebenes Haut\u00f6dem [About an acute described skin edema]","volume":"1","author":"Quincke","year":"1882","journal-title":"Monatshe Prakt Dermatol"},{"key":"10.1016\/j.jaci.2004.06.047_bib5","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/00000441-188804000-00004","article-title":"Hereditary angio-neurotic oedema","volume":"95","author":"Osler","year":"1888","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jaci.2004.06.047_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0002-9343(63)90162-1","article-title":"A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C' 1-esterase","volume":"35","author":"Donaldson","year":"1963","journal-title":"Am J Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00005792-199207000-00003","article-title":"Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients","volume":"71","author":"Agostoni","year":"1992","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaci.2004.06.047_bib8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1067\/mai.2000.108106","article-title":"Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema","volume":"106","author":"Binkley","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib9","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1172\/JCI200214211","article-title":"Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor","volume":"109","author":"Han","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.06.047_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2500\/108854197778594098","article-title":"Complement abnormalities with lower extremities discomfort in Vietnamese immigrants","volume":"18","author":"Luong","year":"1997","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2004.06.047_bib11","first-page":"174","article-title":"Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema (H.A.N.E.) plasma","volume":"90","author":"Donaldson","year":"1977","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1016\/j.jaci.2004.06.047_bib12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0091-6749(83)90052-0","article-title":"Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of \u201cspontaneous\u201d formation of bradykinin","volume":"72","author":"Fields","year":"1983","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib13","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM200208223470820","article-title":"Bradykinin-mediated angioedema","volume":"347","author":"Nussberger","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib14","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(97)09137-X","article-title":"Plasma bradykinin in angio-oedema","volume":"351","author":"Nussberger","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2004.06.047_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.transci.2003.08.012","article-title":"The pathogenesis of hereditary angioedema","volume":"29","author":"Davis","year":"2003","journal-title":"Transfus Apheresis Sci"},{"key":"10.1016\/j.jaci.2004.06.047_bib16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1567-5769(02)00162-5","article-title":"Bradykinin and the pathophysiology of angioedema","volume":"3","author":"Cugno","year":"2003","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaci.2004.06.047_bib17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0162-3109(96)00086-0","article-title":"Activation of factor XII and cleavage of high molecular weight kininogen during acute attacks in hereditary and acquired C1-inhibitor deficiencies","volume":"33","author":"Cugno","year":"1996","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.jaci.2004.06.047_bib18","first-page":"212","article-title":"Endothelial cells contribute to vascular leakage in patients with C1 inhibitor deficiency and angioedema","volume":"41","author":"Bossi","year":"2004","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib19","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1073\/pnas.022626899","article-title":"Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII","volume":"99","author":"Joseph","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2004.06.047_bib20","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S1567-5769(02)00186-8","article-title":"Activation of the bradykinin-forming cascade on endothelial cells: a role for heat shock protein 90","volume":"2","author":"Joseph","year":"2002","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaci.2004.06.047_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0300-483X(02)00584-X","article-title":"Exogenous oestrogen as an alternative to food allergy in the aetiology of angioneurotic oedema","volume":"185","author":"Andre","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.jaci.2004.06.047_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1440-0960.1992.tb00050.x","article-title":"Hormonally exacerbated hereditary angioedema","volume":"33","author":"Yip","year":"1992","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaci.2004.06.047_bib22a","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/art.1780221118","article-title":"Effect of sex hormones on the complement-related clinical disorder of hereditary angioedema","volume":"22","author":"Frank","year":"1979","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2004.06.047_bib23","first-page":"507","article-title":"[Contraception and pregnancy in hereditary angioedema]","volume":"112","author":"Boeckers","year":"1987","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.jaci.2004.06.047_bib23a","first-page":"2023","article-title":"[Norgestrienone, a possible therapeutic agent in hereditary angioneurotic edema]","volume":"15","author":"Wautier","year":"1986","journal-title":"Presse Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1365-2796.1996.418764000.x","article-title":"Hereditary angio-oedema: new clinical observations and autoimmune screening, complement and kallikrein-kinin analyses","volume":"239","author":"Nielsen","year":"1996","journal-title":"J Intern Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib24a","first-page":"2132","article-title":"[Hereditary angioneurotic edema: norgestrienone is not effective in every case]","volume":"16","author":"Laurent","year":"1987","journal-title":"Presse Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0002-9378(81)90611-6","article-title":"Danazol: endocrine pharmacology and therapeutic applications","volume":"141","author":"Barbieri","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaci.2004.06.047_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2222.1971.tb03021.x","article-title":"Hereditary angio-oedema: a review with particular reference to pathogenesis and treatment","volume":"1","author":"Hadjiyannaki","year":"1971","journal-title":"Clin Allergy"},{"key":"10.1016\/j.jaci.2004.06.047_bib27","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0091-6749(99)70030-8","article-title":"Local bradykinin generation in hereditary angioedema","volume":"104","author":"Nussberger","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib28","doi-asserted-by":"crossref","first-page":"983","DOI":"10.4049\/jimmunol.159.2.983","article-title":"Role of the P2 residue of complement 1 inhibitor (Ala443) in determination of target protease specificity: inhibition of complement and contact system proteases","volume":"159","author":"Zahedi","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib29","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S1567-5769(02)00185-6","article-title":"Post-translational mechanisms of endothelial nitric oxide synthase regulation by bradykinin","volume":"2","author":"Venema","year":"2002","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaci.2004.06.047_bib30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1067\/mai.2002.121316","article-title":"Pathways for bradykinin formation and inflammatory disease","volume":"109","author":"Kaplan","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib31","doi-asserted-by":"crossref","first-page":"580","DOI":"10.7326\/0003-4819-84-5-580","article-title":"Hereditary angioedema: the clinical syndrome and its management","volume":"84","author":"Frank","year":"1976","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1365-2796.1997.76893000.x","article-title":"Type I hereditary angio-oedema: variability of clinical presentation and course within two large kindreds","volume":"241","author":"Winnewisser","year":"1997","journal-title":"J Intern Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib33","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0171-2985(98)80041-7","article-title":"Pathogenetic and clinical aspects of C1 inhibitor deficiency","volume":"199","author":"Cicardi","year":"1998","journal-title":"Immunobiology"},{"key":"10.1016\/j.jaci.2004.06.047_bib34","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/BF03042666","article-title":"[Hypovolemic shock caused by ascites in hereditary angioedema]","volume":"93","author":"Bork","year":"1998","journal-title":"Med Klin (Munich)"},{"key":"10.1016\/j.jaci.2004.06.047_bib35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00004836-199304000-00016","article-title":"Hereditary angioneurotic edema with severe hypovolemic shock","volume":"16","author":"Cohen","year":"1993","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jaci.2004.06.047_bib36","first-page":"471","article-title":"Hereditary angioedema: an infrequent cause of abdominal pain with ascites","volume":"90","author":"Talavera","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2004.06.047_bib37","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s002470000409","article-title":"Sonographic appearances of the abdominal manifestations of hereditary angioedema","volume":"31","author":"Dinkel","year":"2001","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.jaci.2004.06.047_bib38","first-page":"307","article-title":"Changes in splenoportal axis calibre and flow in a patient affected by hereditary angioedema","volume":"43","author":"Campanile","year":"2001","journal-title":"Panminerva Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib39","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/(SICI)1097-0096(199911\/12)27:9<537::AID-JCU9>3.0.CO;2-L","article-title":"Sonographic findings in abdominal hereditary angioedema","volume":"27","author":"Sofia","year":"1999","journal-title":"J Clin Ultrasound"},{"key":"10.1016\/j.jaci.2004.06.047_bib40","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2214\/ajr.176.3.1760649","article-title":"CT of angioedema of the small bowel","volume":"176","author":"De Backer","year":"2001","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jaci.2004.06.047_bib41","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0016-5085(99)70170-8","article-title":"Image of the month: hereditary angioedema (HAE)","volume":"116","author":"Wong","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2004.06.047_bib42","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1055\/s-1999-14","article-title":"Hereditary angioedema with gastrointestinal involvement: endoscopic appearance","volume":"31","author":"Hara","year":"1999","journal-title":"Endoscopy"},{"key":"10.1016\/j.jaci.2004.06.047_bib43","first-page":"464","article-title":"Abdominal attack of hereditary angioedema associated with marked leucocytosis: a case report","volume":"24","author":"Calbo","year":"1992","journal-title":"Ital J Gastroenterol"},{"key":"10.1016\/j.jaci.2004.06.047_bib43a","first-page":"285","article-title":"[Hereditary or acquired angioedema caused by functional deficiency of C1 inhibitor\u2013a still unfamiliar disease picture]","volume":"129","author":"W\u00fcthrich","year":"1999","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1016\/j.jaci.2004.06.047_bib44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4065\/75.4.349","article-title":"Asphyxiation by laryngeal edema in patients with hereditary angioedema","volume":"75","author":"Bork","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaci.2004.06.047_bib45","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archinte.161.5.714","article-title":"Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema","volume":"161","author":"Bork","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib46","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/000155501317140188","article-title":"Erythema marginatum preceding an acute oedematous attack of hereditary angioneurotic oedema","volume":"81","author":"Farkas","year":"2001","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2004.06.047_bib47","first-page":"251","article-title":"[Respiratory manifestations in hereditary angioneurotic edema]","volume":"41","author":"Legendre","year":"1985","journal-title":"Rev Pneumol Clin"},{"key":"10.1016\/j.jaci.2004.06.047_bib48","first-page":"277","article-title":"Bladder involvement in hereditary angioedema","volume":"55","author":"Van Dellen","year":"1980","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaci.2004.06.047_bib49","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.1982.03320390067048","article-title":"Neurological manifestations of angioedema: report of two cases and review of the literature","volume":"247","author":"Sunder","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2004.06.047_bib50","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0022-510X(79)90175-8","article-title":"[Cerebral manifestations in angioneurotic edema (author's translation)]","volume":"42","author":"Krause","year":"1979","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jaci.2004.06.047_bib51","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/0021-8707(62)90031-X","article-title":"Hereditary angioneurotic edema, I: case reports and review of the literature","volume":"33","author":"Landerman","year":"1962","journal-title":"J Allergy"},{"issue":"suppl 6","key":"10.1016\/j.jaci.2004.06.047_bib52","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1097\/00005344-199015061-00010","article-title":"Hemodynamic effects of bradykinin on systemic and pulmonary circulation in healthy and hypertensive humans","volume":"15","author":"Bonner","year":"1990","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jaci.2004.06.047_bib53","first-page":"134","article-title":"Analysis of an exon 1 polymorphism of the B2 bradykinin receptor gene and its transcript in normal subjects and patients with C1 inhibitor deficiency","volume":"99","author":"Lung","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib54","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(01)06720-4","article-title":"Eradication of Helicobacter pylori and improvement of hereditary angioneurotic oedema","volume":"358","author":"Farkas","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2004.06.047_bib55","first-page":"53","article-title":"Contributions to the study of the favouring role of chronic urinary infections in inducing and starting drug-allergic-type reactions","volume":"28","author":"Iamandescu","year":"1990","journal-title":"Med Interne"},{"key":"10.1016\/j.jaci.2004.06.047_bib56","first-page":"129","article-title":"Acquired angioedema associated with sinusitis","volume":"10","author":"Watson","year":"2000","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib57","first-page":"753","article-title":"Helicobacter pylori infection and skin diseases","volume":"50","author":"Wedi","year":"1999","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.jaci.2004.06.047_bib58","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000248363","article-title":"Hereditary angioedema associated with subacute cutaneous lupus erythematosus","volume":"179","author":"Gudat","year":"1989","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaci.2004.06.047_bib59","first-page":"700","article-title":"Rheumatoid arthritis and hereditary angioedema","volume":"15","author":"Duncan","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaci.2004.06.047_bib60","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0091-6749(86)90424-0","article-title":"Immunoregulatory disorders associated with hereditary angioedema, I: clinical manifestations of autoimmune disease","volume":"77","author":"Brickman","year":"1986","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib61","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/0091-6749(86)90425-2","article-title":"Immunoregulatory disorders associated with hereditary angioedema, II: serologic and cellular abnormalities","volume":"77","author":"Brickman","year":"1986","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib62","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1346-8138.2002.tb00316.x","article-title":"Lupus erythematosus associated with C1 inhibitor deficiency","volume":"29","author":"Koide","year":"2002","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2004.06.047_bib63","first-page":"378","article-title":"C1 inhibitor deficiency in a patient with rheumatoid arthritis\u2014increased risk of adverse effects of penicillamine?","volume":"23","author":"Sturfelt","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaci.2004.06.047_bib64","first-page":"259","article-title":"Glomerulonephritis and hereditary angioedema: report of 2 cases","volume":"31","author":"Hory","year":"1989","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jaci.2004.06.047_bib65","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/0002-9343(87)90173-2","article-title":"A family with hereditary angioedema and multiple immunologic disorders","volume":"82","author":"Ley","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib66","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1002\/art.1780210923","article-title":"Association of systemic lupus erythematosus and SLE-like syndromes with hereditary and acquired complement deficiency states","volume":"21","author":"Agnello","year":"1978","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2004.06.047_bib67","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0272-6386(12)80830-4","article-title":"Long-term follow-up of non-systemic lupus erythematosus glomerulonephritis in patients with hereditary angioedema: report of four cases","volume":"19","author":"Pan","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jaci.2004.06.047_bib68","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2169\/internalmedicine1962.25.281","article-title":"A case of hereditary angioneurotic edema associated with systemic lupus erythematosus","volume":"25","author":"Suzuki","year":"1986","journal-title":"Jpn J Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib69","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0165-2478(87)90098-8","article-title":"Inherited deficiencies of complement components in man","volume":"14","author":"Alper","year":"1987","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jaci.2004.06.047_bib70","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/clin.1997.4412","article-title":"Epidemiology and estimated population burden of selected autoimmune diseases in the United States","volume":"84","author":"Jacobson","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.jaci.2004.06.047_bib71","first-page":"455","article-title":"Hereditary angioneurotic edema and Charcot-Marie-Tooth disease in the same family","volume":"119","author":"Fernandez","year":"1978","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.jaci.2004.06.047_bib72","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-4608(96)00218-X","article-title":"Association of hereditary angioedema and hereditary breast cancer","volume":"95","author":"Christie","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.jaci.2004.06.047_bib73","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1111\/j.1572-0241.2002.06059.x","article-title":"Association of celiac disease and hereditary angioneurotic edema","volume":"97","author":"Farkas","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2004.06.047_bib74","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/08820139909022722","article-title":"Coincidence of hereditary angioedema (HAE) with Crohn's disease","volume":"28","author":"Farkas","year":"1999","journal-title":"Immunol Invest"},{"key":"10.1016\/j.jaci.2004.06.047_bib75","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1537-2995.1995.35395184276.x","article-title":"Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate","volume":"35","author":"Cicardi","year":"1995","journal-title":"Transfusion"},{"key":"10.1016\/j.jaci.2004.06.047_bib76","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(88)91558-9","article-title":"Ultrasonography in the diagnosis of hereditary angioneurotic oedema","volume":"1","author":"Laurent","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2004.06.047_bib77","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(87)92371-3","article-title":"Ultrasonography for early diagnosis of hereditary angioneurotic oedema","volume":"2","author":"Burghardt","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2004.06.047_bib78","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1097\/00042737-200110000-00016","article-title":"Ultrasonography in the diagnosis and monitoring of ascites in acute abdominal attacks of hereditary angioneurotic oedema","volume":"13","author":"Farkas","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2004.06.047_bib79","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1034\/j.1399-3038.2002.01014.x","article-title":"Clinical management of hereditary angio-oedema in children","volume":"13","author":"Farkas","year":"2002","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib80","series-title":"General ultrasound","year":"1992"},{"key":"10.1016\/j.jaci.2004.06.047_bib81","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1651-2227.2002.tb02864.x","article-title":"Acute abdominal attack of hereditary angioneurotic oedema associated with ultrasound abnormalities suggestive of acute hepatitis","volume":"91","author":"Farkas","year":"2002","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jaci.2004.06.047_bib82","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0190-9622(91)70183-3","article-title":"Angioedema: manifestations and management","volume":"25","author":"Greaves","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2004.06.047_bib83","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/archinte.161.20.2417","article-title":"Hereditary angioedema: a broad review for clinicians","volume":"161","author":"Nzeako","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib84","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1067\/mai.2000.104780","article-title":"Detection of C1 inhibitor mutations in patients with hereditary angioedema","volume":"105","author":"Zuraw","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib85","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/clim.2000.4947","article-title":"A review of the reported defects in the human C1 esterase inhibitor gene producing hereditary angioedema including four new mutations","volume":"98","author":"Bowen","year":"2001","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib86","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(00)02483-1","article-title":"Hereditary angioedema with normal C1-inhibitor activity in women","volume":"356","author":"Bork","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2004.06.047_bib87","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1067\/mai.2001.114242","article-title":"Hereditary angioedema type III: an additional French pedigree with autosomal dominant transmission","volume":"107","author":"Martin","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib88","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.148.3672.957","article-title":"Hereditary angioneurotic edema: two genetic variants","volume":"148","author":"Rosen","year":"1965","journal-title":"Science"},{"key":"10.1016\/j.jaci.2004.06.047_bib89","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1146\/annurev.iy.06.040188.003115","article-title":"C1 inhibitor and hereditary angioneurotic edema","volume":"6","author":"Davis","year":"1988","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib90","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1172\/JCI110831","article-title":"Behavior in vivo of normal and dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioneurotic edema","volume":"71","author":"Quastel","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.06.047_bib91","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1172\/JCI117663","article-title":"Crucial residues in the carboxy-terminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function","volume":"95","author":"Verpy","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.06.047_bib92","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.transci.2003.08.002","article-title":"Estrogen-dependent inherited angioedema","volume":"29","author":"Binkley","year":"2003","journal-title":"Transfus Apheresis Sci"},{"key":"10.1016\/j.jaci.2004.06.047_bib93","first-page":"H1340","article-title":"Serum interspecies differences in metabolic pathways of bradykinin and [des-Arg9]BK: influence of enalaprilat","volume":"271","author":"Decarie","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jaci.2004.06.047_bib94","series-title":"Handbook of immunopharmacology: the kinin system","first-page":"111","article-title":"Metabolism of bradykinin in health and disease","author":"Erdos","year":"1997"},{"key":"10.1016\/j.jaci.2004.06.047_bib95","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0196-9781(99)00020-0","article-title":"Des-Arg9-bradykinin metabolism in patients who presented hypersensitivity reactions during hemodialysis: role of serum ACE and aminopeptidase P","volume":"20","author":"Blais","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/j.jaci.2004.06.047_bib96","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/S0140-6736(02)08914-6","article-title":"Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors","volume":"359","author":"Adam","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2004.06.047_bib97","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/0002-9343(90)90514-E","article-title":"Possible contraindication of angiotensin converting enzyme inhibitors in patients with hereditary angioedema","volume":"88","author":"Shepherd","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib98","first-page":"134","article-title":"Exacerbation of angioedema by an angiotensin converting enzyme inhibitor in a patient with variant form hereditary angioedema","volume":"1","author":"Binkley","year":"1996","journal-title":"Can J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib99","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0162-3109(99)00107-1","article-title":"Angioedema due to angiotensin-converting enzyme inhibitors","volume":"44","author":"Agostoni","year":"1999","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.jaci.2004.06.047_bib100","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S1081-1206(10)62208-9","article-title":"Hereditary angioedema first apparent in the ninth decade during treatment with ACE inhibitor","volume":"87","author":"Berkun","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib101","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1067\/mai.2001.114243","article-title":"Reply (Hereditary angioedema type III: an additional French pedigree with autosomal dominant transmission)","volume":"107","author":"Binkley","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib102","series-title":"The complement system","article-title":"Inherited and acquired deficiencies of C1 esterase inhibitor in man","author":"Day","year":"1988"},{"key":"10.1016\/j.jaci.2004.06.047_bib103","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/S0140-6736(05)74078-2","article-title":"Hereditary angioedema and normal C1-inhibitor activity in women","volume":"356","author":"Kranke","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2004.06.047_bib104","doi-asserted-by":"crossref","first-page":"739","DOI":"10.7326\/0003-4819-53-4-739","article-title":"Methyltestosterone therapy for hereditary episodic edema (hereditary angioneurotic edema)","volume":"53","author":"Spaulding","year":"1960","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00005792-197907000-00004","article-title":"Acquired C1 esterase inhibitor deficiency and angioedema: a review","volume":"58","author":"Gelfand","year":"1979","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaci.2004.06.047_bib106","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0091-6749(87)80277-4","article-title":"Hereditary angioedema: a decade of management with stanozolol","volume":"80","author":"Sheffer","year":"1987","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib107","first-page":"762","article-title":"Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives","volume":"96","author":"Gordon","year":"1980","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib108","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0049-3848(81)90206-1","article-title":"C1 inactivator level in pregnancy","volume":"23","author":"Ogston","year":"1981","journal-title":"Thromb Res"},{"key":"10.1016\/j.jaci.2004.06.047_bib109","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0038-1647471","article-title":"C1-esterase inhibitor in uncomplicated pregnancy and mild and moderate preeclampsia","volume":"65","author":"Halbmayer","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaci.2004.06.047_bib110","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0091-6749(05)80025-9","article-title":"C1 esterase inhibitor in pregnancy","volume":"90","author":"Cohen","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib111","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0090-1229(72)90006-2","article-title":"Acquired C1 inhibitor deficiency in lymphosarcoma","volume":"1","author":"Caldwell","year":"1972","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.jaci.2004.06.047_bib112","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0091-6749(86)80111-7","article-title":"The metabolism of C1 inhibitor and C1q in patients with acquired C1-inhibitor deficiency","volume":"77","author":"Melamed","year":"1986","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib113","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/archinte.1989.00390050159036","article-title":"Acquired angioedema and anti-C1-inhibitor autoantibody","volume":"149","author":"Spath","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib114","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0002-9343(93)90257-P","article-title":"Autoimmune C1 inhibitor deficiency: report of eight patients","volume":"95","author":"Cicardi","year":"1993","journal-title":"Am J Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib115","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2249.1996.d01-866.x","article-title":"Relevance of lymphoproliferative disorders and of anti-C1 inhibitor autoantibodies in acquired angio-oedema","volume":"106","author":"Cicardi","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib116","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V48.4.567.567","article-title":"Acquired angioedema with lymphoproliferative disorder: association of C1 inhibitor deficiency with cellular abnormality","volume":"48","author":"Schreiber","year":"1976","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2004.06.047_bib117","first-page":"523","article-title":"Acquired C1 inhibitor deficiency in a case of lymphosarcoma of the spleen: reversal of complement abnormalities after splenectomy","volume":"37","author":"Hauptmann","year":"1979","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib118","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000467853","article-title":"Acquired C1 inhibitor deficiency with angioedema symptoms in a patient infected with Echinococcus granulosus","volume":"2","author":"Cicardi","year":"1985","journal-title":"Complement"},{"key":"10.1016\/j.jaci.2004.06.047_bib119","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0091-6749(99)70248-4","article-title":"Acquired angioedema associated with chronic hepatitis C","volume":"103","author":"Farkas","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib120","first-page":"513","article-title":"Angioedema due to acquired C1-esterase inhibitor deficiency in a patient with Helicobacter pylori infection","volume":"37","author":"Farkas","year":"1999","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.jaci.2004.06.047_bib121","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/00015550152572985","article-title":"Angiooedema due to acquired deficiency of C1-esterase inhibitor associated with leucocytoclastic vasculitis","volume":"81","author":"Farkas","year":"2001","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2004.06.047_bib122","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/0091-6749(85)90087-9","article-title":"Acquired deficiency of the inhibitor of the first component of complement: report of five additional cases with commentary on the syndrome","volume":"75","author":"Sheffer","year":"1985","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib123","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0002-9343(87)90659-0","article-title":"Recurrent febrile panniculitis and hepatitis in two patients with acquired complement deficiency and paraproteinemia","volume":"83","author":"Pascual","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib124","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/ard.50.10.713","article-title":"Acquired C1 inhibitor deficiency associated with systemic lupus erythematosus affecting the central nervous system","volume":"50","author":"Nakamura","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2004.06.047_bib125","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/art.10342","article-title":"Acquired C1 esterase inhibitor deficiency in two patients presenting with a lupus-like syndrome and anticardiolipin antibodies","volume":"47","author":"Barilla-LaBarca","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2004.06.047_bib126","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0025-6196(12)61290-7","article-title":"Angioedema with acquired deficiency of the C1 inhibitor: a constellation of syndromes","volume":"64","author":"Frigas","year":"1989","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaci.2004.06.047_bib127","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/323722a0","article-title":"An IgG autoantibody which inactivates C1-inhibitor","volume":"323","author":"Jackson","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2004.06.047_bib128","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1172\/JCI113934","article-title":"Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema","volume":"83","author":"Jackson","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.06.047_bib129","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1172\/JCI114084","article-title":"Acquired C1 inhibitor (C1-INH) deficiency type II: replacement therapy with C1-INH and analysis of patients' C1-INH and anti-C1-INH autoantibodies","volume":"83","author":"Alsenz","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.06.047_bib130","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1365-2249.1996.d01-879.x","article-title":"Autoimmune C1-inhibitor deficiency","volume":"106","author":"Whaley","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib131","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000018252","article-title":"Acquired angioedema with C1 inhibitor deficiency: is the distinction between type I and type II still relevant?","volume":"199","author":"D'Incan","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.jaci.2004.06.047_bib132","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0002-9343(02)01124-5","article-title":"Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2","volume":"113","author":"Fremeaux-Bacchi","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib133","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0002-9343(03)00396-6","article-title":"Clinical and biological distinctions between type I and type II acquired angioedema","volume":"115","author":"Bouillet-Claveyrolas","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib134","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/01.md.0000085055.63483.09","article-title":"Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies","volume":"82","author":"Cicardi","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaci.2004.06.047_bib135","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0002-9343(99)00123-0","article-title":"Idiopathic nonhistaminergic angioedema","volume":"106","author":"Cicardi","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib136","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2165\/00002018-200124080-00004","article-title":"Drug-induced angioedema without urticaria","volume":"24","author":"Agostoni","year":"2001","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaci.2004.06.047_bib137","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1345\/aph.1C520","article-title":"Valsartan-induced angioedema","volume":"37","author":"Irons","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaci.2004.06.047_bib138","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000467830","article-title":"Quantification of C1-inhibitor functional activities by immunodiffusion assay in plasma of patients with hereditary angioedema\u2014evidence of a functionally critical level of C1-inhibitor concentration","volume":"1","author":"Spath","year":"1984","journal-title":"Complement"},{"key":"10.1016\/j.jaci.2004.06.047_bib139","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0014-5793(79)80063-0","article-title":"Interaction of 125I-labelled complement subcomponents C-1r and C-1s with protease inhibitors in plasma","volume":"97","author":"Sim","year":"1979","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jaci.2004.06.047_bib140","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1172\/JCI111360","article-title":"Inactivation of factor XII active fragment in normal plasma: predominant role of C-1-inhibitor","volume":"73","author":"de Agostini","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.06.047_bib141","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1016\/S0021-9258(18)89258-4","article-title":"Distribution of plasma kallikrein between C-1 inactivator and alpha 2-macroglobulin in plasma utilizing a new assay for alpha 2-macroglobulin-kallikrein complexes","volume":"260","author":"Harpel","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2004.06.047_bib142","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1055\/s-0038-1653798","article-title":"On the role of C1-inhibitor as inhibitor of tissue-type plasminogen activator in human plasma","volume":"73","author":"Huisman","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaci.2004.06.047_bib143","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1182\/blood.V85.6.1517.bloodjournal8561517","article-title":"Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes: major role for C1-inhibitor","volume":"85","author":"Wuillemin","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2004.06.047_bib144","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.4049\/jimmunol.165.5.2637","article-title":"Proteolytic activities of two types of mannose-binding lectin-associated serine protease","volume":"165","author":"Matsushita","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib145","doi-asserted-by":"crossref","first-page":"15957","DOI":"10.1016\/S0021-9258(17)33954-6","article-title":"The serpin superfamily of proteinase inhibitors: structure, function, and regulation","volume":"269","author":"Potempa","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2004.06.047_bib146","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF00195824","article-title":"Regional assignment of the human C1-inhibitor gene to 11q11-q13.1","volume":"84","author":"Theriault","year":"1990","journal-title":"Hum Genet"},{"key":"10.1016\/j.jaci.2004.06.047_bib147","doi-asserted-by":"crossref","first-page":"10609","DOI":"10.1073\/pnas.88.23.10609","article-title":"Detailed physical map of human chromosomal region 11q12-13 shows high meiotic recombination rate around the MEN1 locus","volume":"88","author":"Janson","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2004.06.047_bib148","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1432-1033.1991.tb15911.x","article-title":"Complete nucleotide sequence of the gene for human C1 inhibitor with an unusually high density of Alu elements","volume":"197","author":"Carter","year":"1991","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jaci.2004.06.047_bib149","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0888-7543(90)90246-Q","article-title":"Recombinations between Alu repeat sequences that result in partial deletions within the C1 inhibitor gene","volume":"8","author":"Ariga","year":"1990","journal-title":"Genomics"},{"key":"10.1016\/j.jaci.2004.06.047_bib150","first-page":"1055","article-title":"Recombinational biases in the rearranged C1-inhibitor genes of hereditary angioedema patients","volume":"49","author":"Stoppa-Lyonnet","year":"1991","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaci.2004.06.047_bib151","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF00212020","article-title":"Contiguous deletion and duplication mutations resulting in type 1 hereditary angioneurotic edema","volume":"93","author":"Bissler","year":"1994","journal-title":"Hum Genet"},{"key":"10.1016\/j.jaci.2004.06.047_bib152","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1016\/S0021-9258(18)94031-7","article-title":"CpG mutations in the reactive site of human C1 inhibitor","volume":"264","author":"Skriver","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2004.06.047_bib153","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0171-2985(98)80040-5","article-title":"Molecular genetics of C1 inhibitor","volume":"199","author":"Tosi","year":"1998","journal-title":"Immunobiology"},{"key":"10.1016\/j.jaci.2004.06.047_bib154","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1067\/mai.2000.110471","article-title":"Frequent de novo mutations and exon deletions in the C1inhibitor gene of patients with angioedema","volume":"106","author":"Pappalardo","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib155","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1074\/jbc.270.6.2579","article-title":"COOH-terminal substitutions in the serpin C1 inhibitor that cause loop overinsertion and subsequent multimerization","volume":"270","author":"Eldering","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2004.06.047_bib156","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1172\/JCI116290","article-title":"Transinhibition of C1 inhibitor synthesis in type I hereditary angioneurotic edema","volume":"91","author":"Kramer","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.06.047_bib157","first-page":"35","article-title":"The catabolism of C1(-)-inhibitor and the pathogenesis of hereditary angio-edema","volume":"284","author":"Lachmann","year":"1984","journal-title":"Acta Pathol Microbiol Immunol Scand Suppl"},{"key":"10.1016\/j.jaci.2004.06.047_bib158","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-4615-5391-5_18","article-title":"C1 inhibitor. Functional analysis of naturally-occurring mutant proteins","volume":"425","author":"Davis","year":"1997","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jaci.2004.06.047_bib159","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ng0892-354","article-title":"C1 inhibitor hinge region mutations produce dysfunction by different mechanisms","volume":"1","author":"Davis","year":"1992","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2004.06.047_bib160","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1172\/JCI117780","article-title":"Unique C1 inhibitor dysfunction in a kindred without angioedema, II: identification of an Ala443\u2013Val substitution and functional analysis of the recombinant mutant protein","volume":"95","author":"Zahedi","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.06.047_bib161","doi-asserted-by":"crossref","first-page":"18088","DOI":"10.1016\/S0021-9258(17)46815-3","article-title":"A hinge region mutation in C1-inhibitor (Ala436\u2013Thr) results in nonsubstrate-like behavior and in polymerization of the molecule","volume":"268","author":"Aulak","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2004.06.047_bib162","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1078\/0171-2985-00151","article-title":"Structural and functional aspects of C1-inhibitor","volume":"205","author":"Bos","year":"2002","journal-title":"Immunobiology"},{"key":"10.1016\/j.jaci.2004.06.047_bib163","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/BF03401772","article-title":"C1 inhibitor gene sequence facilitates frameshift mutations","volume":"4","author":"Bissler","year":"1998","journal-title":"Mol Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib164","series-title":"The human complement system in health and disease","first-page":"455","article-title":"C1 inhibitor gene and hereditary angioedema","author":"Davis","year":"1998"},{"key":"10.1016\/j.jaci.2004.06.047_bib165","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng1093-111","article-title":"The rapid detection of unknown mutations in nucleic acids","volume":"5","author":"Grompe","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2004.06.047_bib166","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1050-3862(98)00029-1","article-title":"Enzymatic methods for mutation scanning","volume":"14","author":"Taylor","year":"1999","journal-title":"Genet Anal"},{"key":"10.1016\/j.jaci.2004.06.047_bib167","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1073\/pnas.85.12.4397","article-title":"Reactivity of cytosine and thymine in single-base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations","volume":"85","author":"Cotton","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2004.06.047_bib168","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/(SICI)1098-1004(1998)11:5<345::AID-HUMU1>3.0.CO;2-0","article-title":"Chemical cleavage of mismatch: a new look at an established method","volume":"11","author":"Ellis","year":"1998","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jaci.2004.06.047_bib169","first-page":"120","article-title":"C1 inhibitor mutations which affect intracellular transport and secretion in type I hereditary angioedema","author":"Verpy","year":"1993","journal-title":"Behring Inst Mitt"},{"key":"10.1016\/j.jaci.2004.06.047_bib170","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0027-5107(93)90060-S","article-title":"Current methods of mutation detection","volume":"285","author":"Cotton","year":"1993","journal-title":"Mutat Res"},{"key":"10.1016\/j.jaci.2004.06.047_bib171","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1073\/pnas.91.5.1873","article-title":"Efficient detection of point mutations on color-coded strands of target DNA","volume":"91","author":"Verpy","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2004.06.047_bib172","first-page":"308","article-title":"Exhaustive mutation scanning by fluorescence-assisted mismatch analysis discloses new genotype-phenotype correlations in angiodema","volume":"59","author":"Verpy","year":"1996","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaci.2004.06.047_bib173","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/humu.1130","article-title":"Denaturing high-performance liquid chromatography: a review","volume":"17","author":"Xiao","year":"2001","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jaci.2004.06.047_bib174","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/humu.1380030202","article-title":"Mutation detection by denaturing gradient gel electrophoresis (DGGE)","volume":"3","author":"Fodde","year":"1994","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jaci.2004.06.047_bib175","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/humu.9029","article-title":"Five novel mutations in the C1 inhibitor gene (C1NH) leading to a premature stop codon in patients with type I hereditary angioedema","volume":"19","author":"Freiberger","year":"2002","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jaci.2004.06.047_bib176","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/(SICI)1522-2683(19990101)20:6<1177::AID-ELPS1177>3.0.CO;2-2","article-title":"Single-strand conformation polymorphism and heteroduplex analysis for gel-based mutation detection","volume":"20","author":"Nataraj","year":"1999","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jaci.2004.06.047_bib177","first-page":"164","article-title":"Molecular defects in hereditary angioneurotic edema","volume":"109","author":"Bissler","year":"1997","journal-title":"Proc Assoc Am Physicians"},{"key":"10.1016\/j.jaci.2004.06.047_bib178","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/humu.9073","article-title":"Detection of C1 inhibitor (SERPING1\/C1NH) mutations in exon 8 in patients with hereditary angioedema: evidence for 10 novel mutations","volume":"20","author":"Blanch","year":"2002","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jaci.2004.06.047_bib179","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1172\/JCI112873","article-title":"Molecular basis for the deficiency of complement 1 inhibitor in type I hereditary angioneurotic edema","volume":"79","author":"Cicardi","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.06.047_bib180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198707023170101","article-title":"Altered C1 inhibitor genes in type I hereditary angioedema","volume":"317","author":"Stoppa-Lyonnet","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib181","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1399-0004.1991.tb03006.x","article-title":"Restriction fragment length polymorphism analysis of the C1-inhibitor gene in hereditary C1-inhibitor deficiency","volume":"39","author":"McPhaden","year":"1991","journal-title":"Clin Genet"},{"key":"10.1016\/j.jaci.2004.06.047_bib182","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/1098-1004(2001)17:1<61::AID-HUMU7>3.0.CO;2-9","article-title":"Rapid detection by fluorescent multiplex PCR of exon deletions and duplications in the C1 inhibitor gene of hereditary angioedema patients","volume":"17","author":"Duponchel","year":"2001","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jaci.2004.06.047_bib183","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1136\/jmg.40.10.e114","article-title":"The effect of sequence variations within the coding region of the C1 inhibitor gene on disease expression and protein function in families with hereditary angio-oedema","volume":"40","author":"Cumming","year":"2003","journal-title":"J Med Genet"},{"key":"10.1016\/j.jaci.2004.06.047_bib184","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.4049\/jimmunol.162.12.7249","article-title":"The promoter of the C1 inhibitor gene contains a polypurine-polypyrimidine segment that enhances transcriptional activity","volume":"162","author":"Zahedi","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib185","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/humu.9202","article-title":"Mutation screening of the C1 inhibitor gene among Hungarian patients with hereditary angioedema","volume":"22","author":"Kalmar","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jaci.2004.06.047_bib186","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/1529-0131(200104)44:4<974::AID-ANR155>3.0.CO;2-1","article-title":"Hereditary angioedema with a de novo mutation of exon 8 in the C1 inhibitor gene showing recurrent edema of the hands around the peripheral joints: importance for the differential diagnosis of joint swelling","volume":"44","author":"Sugiyama","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2004.06.047_bib187","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1172\/JCI114095","article-title":"Type I C1 inhibitor deficiency with a small messenger RNA resulting from deletion of one exon","volume":"83","author":"Ariga","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.06.047_bib188","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1172\/JCI115175","article-title":"Synthesis of C1 inhibitor in fibroblasts from patients with type I and type II hereditary angioneurotic edema","volume":"87","author":"Kramer","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.06.047_bib189","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4049\/jimmunol.157.1.405","article-title":"Impaired production of both normal and mutant C1 inhibitor proteins in type I hereditary angioedema with a duplication in exon 8","volume":"157","author":"Ernst","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib190","doi-asserted-by":"crossref","first-page":"11776","DOI":"10.1016\/S0021-9258(18)37851-7","article-title":"Expression of functional human C1 inhibitor in COS cells","volume":"263","author":"Eldering","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2004.06.047_bib191","doi-asserted-by":"crossref","first-page":"7013","DOI":"10.1016\/S0021-9258(19)50529-4","article-title":"Characterization of recombinant C1 inhibitor P1 variants","volume":"267","author":"Eldering","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2004.06.047_bib192","doi-asserted-by":"crossref","first-page":"24307","DOI":"10.1074\/jbc.271.39.24307","article-title":"Characterization of C1 inhibitor-Ta: a dysfunctional C1INH with deletion of lysine 251","volume":"271","author":"Zahedi","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2004.06.047_bib193","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.4049\/jimmunol.167.3.1500","article-title":"C1 inhibitor: analysis of the role of amino acid residues within the reactive center loop in target protease recognition","volume":"167","author":"Zahedi","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib194","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/0006-291X(80)90867-0","article-title":"A surprising new protein superfamily containing ovalbumin, antithrombin-III, and alpha 1-proteinase inhibitor","volume":"95","author":"Hunt","year":"1980","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jaci.2004.06.047_bib195","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/S0021-9258(18)89572-2","article-title":"Primary structure of the reactive site of human C1-inhibitor","volume":"260","author":"Salvesen","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2004.06.047_bib196","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0378-1119(86)90230-1","article-title":"Molecular cloning of human C1 inhibitor: sequence homologies with alpha 1-antitrypsin and other members of the serpins superfamily","volume":"42","author":"Tosi","year":"1986","journal-title":"Gene"},{"key":"10.1016\/j.jaci.2004.06.047_bib197","doi-asserted-by":"crossref","first-page":"33293","DOI":"10.1074\/jbc.R100016200","article-title":"The serpins are an expanding superfamily of structurally similar but functionally diverse proteins: evolution, mechanism of inhibition, novel functions, and a revised nomenclature","volume":"276","author":"Silverman","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2004.06.047_bib198","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0031-6997(24)01437-6","article-title":"C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema","volume":"52","author":"Caliezi","year":"2000","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jaci.2004.06.047_bib199","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00001721-200106000-00005","article-title":"In vitro interaction of C1-inhibitor with thrombin","volume":"12","author":"Cugno","year":"2001","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jaci.2004.06.047_bib200","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1172\/JCI106267","article-title":"C1 inactivator inhibition by plasmin","volume":"49","author":"Harpel","year":"1970","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.06.047_bib201","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood.V69.6.1600.1600","article-title":"Plasminogen activator in normal subjects after exercise and venous occlusion: t-PA circulates as complexes with C1-inhibitor and PAI-1","volume":"69","author":"Booth","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2004.06.047_bib202","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.4049\/jimmunol.159.4.1953","article-title":"Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma","volume":"159","author":"Wuillemin","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib203","doi-asserted-by":"crossref","first-page":"12913","DOI":"10.1074\/jbc.271.22.12913","article-title":"Modulation of contact system proteases by glycosaminoglycans: selective enhancement of the inhibition of factor XIa","volume":"271","author":"Wuillemin","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2004.06.047_bib204","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S1567-5769(01)00073-X","article-title":"The potentiation of human C1-inhibitor by dextran sulphate is transient in vivo: studies in a rat model","volume":"1","author":"Bos","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaci.2004.06.047_bib205","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1021\/bi00363a018","article-title":"Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization","volume":"25","author":"Bock","year":"1986","journal-title":"Biochemistry"},{"key":"10.1016\/j.jaci.2004.06.047_bib206","doi-asserted-by":"crossref","first-page":"29463","DOI":"10.1074\/jbc.M302977200","article-title":"The functional integrity of the serpin domain of C1-inhibitor depends on the unique N-terminal domain, as revealed by a pathological mutant","volume":"278","author":"Bos","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2004.06.047_bib207","first-page":"1","article-title":"Simultaneous turnover of normal and dysfunctional C1 inhibitor as a probe of in vivo activation of C1 and contact activatable proteases","volume":"61","author":"Woo","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib208","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0171-2985(98)80042-9","article-title":"Regulation of C1 inhibitor synthesis","volume":"199","author":"Prada","year":"1998","journal-title":"Immunobiology"},{"key":"10.1016\/j.jaci.2004.06.047_bib209","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4049\/jimmunol.126.1.245","article-title":"The role of sialic acid in the functional activity and the hepatic clearance of C1-INH","volume":"126","author":"Minta","year":"1981","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib210","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/blood.V81.1.56.56","article-title":"Clearance of human native, proteinase-complexed, and proteolytically inactivated C1-inhibitor in rats","volume":"81","author":"de Smet","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2004.06.047_bib211","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1046\/j.1537-2995.1998.38698326333.x","article-title":"A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema","volume":"38","author":"Kunschak","year":"1998","journal-title":"Transfusion"},{"key":"10.1016\/j.jaci.2004.06.047_bib212","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.4049\/jimmunol.128.6.2505","article-title":"A new role for C-1-inhibitor in homeostasis: control of activation of the first component of human complement","volume":"128","author":"Ziccardi","year":"1982","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib213","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1365-3083.1996.d01-298.x","article-title":"Activation of the complement, coagulation, fibrinolytic and kallikrein-kinin systems during attacks of hereditary angioedema","volume":"44","author":"Nielsen","year":"1996","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib214","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.4049\/jimmunol.124.6.2780","article-title":"Activation of the fourth component of complement (C4): assessment by rocket immunoelectrophoresis and correlation with the metabolism of C4","volume":"124","author":"Milgrom","year":"1980","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib215","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.20020542","article-title":"I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation","volume":"196","author":"Kim","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib216","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1084\/jem.192.9.1353","article-title":"C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity","volume":"192","author":"Gershov","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib217","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.4049\/jimmunol.158.10.4525","article-title":"C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited","volume":"158","author":"Korb","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib218","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4049\/jimmunol.167.2.647","article-title":"Chromatin-independent binding of serum amyloid P component to apoptotic cells","volume":"167","author":"Familian","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib219","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1172\/JCI111326","article-title":"Surface-mediated defense reactions: the plasma contact activation system","volume":"73","author":"Colman","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.06.047_bib220","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1182\/blood.V72.6.1841.1841","article-title":"Quantification of plasma factor XIIa-C1-inhibitor and kallikrein-C1-inhibitor complexes in sepsis","volume":"72","author":"Nuijens","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2004.06.047_bib221","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJM198305053081802","article-title":"Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema","volume":"308","author":"Schapira","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib222","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1182\/blood.V89.9.3213","article-title":"Activation of the coagulation cascade in C1-inhibitor deficiencies","volume":"89","author":"Cugno","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2004.06.047_bib223","first-page":"38","article-title":"Generation of plasmin during acute attacks of hereditary angioedema","volume":"121","author":"Cugno","year":"1993","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib224","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1055\/s-0038-1650621","article-title":"Inactivation of factor XIa in vivo: studies in chimpanzees and in humans","volume":"76","author":"Wuillemin","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaci.2004.06.047_bib225","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1172\/JCI115416","article-title":"Reduction of contact activation related fibrinolytic activity in factor XII deficient patients: further evidence for the role of the contact system in fibrinolysis in vivo","volume":"88","author":"Levi","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.06.047_bib226","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/blood.V92.2.703","article-title":"The role of factor XII in contact system activation","volume":"92","author":"Hack","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2004.06.047_bib227","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJM199810293391804","article-title":"Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects","volume":"339","author":"Gainer","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib228","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jphs.93.1","article-title":"Roles for the kallikrein-kinin system in inflammatory exudation and pain: lessons from studies on kininogen-deficient rats","volume":"93","author":"Ueno","year":"2003","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.jaci.2004.06.047_bib229","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1084\/jem.168.5.1685","article-title":"Angioedema induced by a peptide derived from complement component C2","volume":"168","author":"Strang","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib230","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1055\/s-0037-1615753","article-title":"Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms","volume":"85","author":"Joop","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaci.2004.06.047_bib231","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1021\/bi00336a047","article-title":"Binding and activation properties of human factor XII, prekallikrein, and derived peptides with acidic lipid vesicles","volume":"24","author":"Griep","year":"1985","journal-title":"Biochemistry"},{"key":"10.1016\/j.jaci.2004.06.047_bib232","first-page":"503","article-title":"Dextran sulphate inhibits phospholipid and sulphatide mediated autoactivation of factor XII","volume":"5","author":"Schousboe","year":"1994","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jaci.2004.06.047_bib233","first-page":"394","article-title":"Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4","volume":"112","author":"Dumenco","year":"1988","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib234","first-page":"519","article-title":"Inhibition of the activation of Hageman factor (factor XII) by beta 2-glycoprotein I","volume":"111","author":"Henry","year":"1988","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib235","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1080\/00016480310005129","article-title":"Angioneurotic edema of the upper airways and antihypertensive therapy","volume":"123","author":"Zanoletti","year":"2003","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.jaci.2004.06.047_bib236","first-page":"519","article-title":"[Vasopeptidases and their inhibitors]","volume":"93","author":"Agostoni","year":"2002","journal-title":"Recenti Prog Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib237","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/01.HYP.0000054215.71691.16","article-title":"Vasopeptidase inhibition: a double-edged sword?","volume":"41","author":"Campbell","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.jaci.2004.06.047_bib238","first-page":"203","article-title":"[Hereditary angioedema: genealogic studies and clinical considerations on 2 genetic forms in a case study of 10 patients]","volume":"121","author":"La Rocca","year":"1986","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.jaci.2004.06.047_bib239","first-page":"956","article-title":"Late angioedema caused by ACE inhibitors underestimated","volume":"66","author":"Pavletic","year":"2002","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jaci.2004.06.047_bib240","first-page":"92","article-title":"Angioedema due to ACE inhibitors: common and inadequately diagnosed","volume":"7","year":"1998","journal-title":"Prescrire Int"},{"key":"10.1016\/j.jaci.2004.06.047_bib241","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0091-6749(96)70151-3","article-title":"Increased sensitivity to bradykinin among African Americans","volume":"98","author":"Gainer","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib242","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-2125.2000.00207.x","article-title":"Angioedema and cough in Nigerian patients receiving ACE inhibitors","volume":"50","author":"Ajayi","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaci.2004.06.047_bib243","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1046\/j.1365-2125.1999.00093.x","article-title":"Angioedema due to ACE inhibitors: increased risk in patients of African origin","volume":"48","author":"Gibbs","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaci.2004.06.047_bib244","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1592\/phco.22.13.1173.33517","article-title":"Angiotensin II receptor blocker-associated angioedema: on the heels of ACE inhibitor angioedema","volume":"22","author":"Abdi","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jaci.2004.06.047_bib245","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1345\/aph.19294","article-title":"Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema","volume":"34","author":"Warner","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaci.2004.06.047_bib246","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1097\/00005537-200110000-00011","article-title":"Angioedema associated with angiotensin II receptor antagonists: challenging our knowledge of angioedema and its etiology","volume":"111","author":"Chiu","year":"2001","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2004.06.047_bib247","doi-asserted-by":"crossref","first-page":"H926","DOI":"10.1152\/ajpheart.00757.2003","article-title":"Mechanisms of angiotensin II-induced expression of B2 kinin receptors","volume":"286","author":"Tan","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jaci.2004.06.047_bib248","first-page":"1414","article-title":"Omapatrilat: Bristol-Myers Squibb","volume":"2","author":"Tabrizchi","year":"2001","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.jaci.2004.06.047_bib249","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.amjhyper.2003.09.014","article-title":"Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial","volume":"17","author":"Kostis","year":"2004","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jaci.2004.06.047_bib250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-5273(02)00389-3","article-title":"Omapatrilat\u2014the story of Overture and Octave","volume":"86","author":"Coats","year":"2002","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jaci.2004.06.047_bib251","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/ndt\/16.8.1532","article-title":"Vasopeptidase inhibitors\u2014concepts and evidence","volume":"16","author":"Ruschitzka","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jaci.2004.06.047_bib252","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/01.STR.0000017284.77838.87","article-title":"Biochemical basis of angioedema associated with recombinant tissue plasminogen activator treatment: an in vitro experimental approach","volume":"33","author":"Molinaro","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.jaci.2004.06.047_bib253","doi-asserted-by":"crossref","first-page":"H275","DOI":"10.1152\/ajpheart.2001.281.1.H275","article-title":"Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma","volume":"281","author":"Cyr","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jaci.2004.06.047_bib254","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0031-6997(25)00058-4","article-title":"Bioregulation of kinins: kallikreins, kininogens, and kininases","volume":"44","author":"Bhoola","year":"1992","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jaci.2004.06.047_bib255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0306-3623(96)00174-7","article-title":"Bradykinin receptors","volume":"28","author":"Hall","year":"1997","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.jaci.2004.06.047_bib256","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1291\/hypres.26.53","article-title":"Effects of hormone replacement therapy on serum angiotensin-converting enzyme activity and plasma bradykinin in postmenopausal women according to angiotensin-converting enzyme-genotype","volume":"26","author":"Sumino","year":"2003","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jaci.2004.06.047_bib257","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0140-6736(95)92114-1","article-title":"Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women","volume":"346","author":"Proudler","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2004.06.047_bib258","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF00915368","article-title":"Decreased synthesis of serum carboxypeptidase N (SCPN) in familial SCPN deficiency","volume":"6","author":"Mathews","year":"1986","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib259","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7326\/0003-4819-93-3-443","article-title":"Familial carboxypeptidase N deficiency","volume":"93","author":"Mathews","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib260","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-0037-1615142","article-title":"Factor XII does not initiate prekallikrein activation on endothelial cells","volume":"80","author":"Rojkjaer","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaci.2004.06.047_bib261","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0162-3109(99)00069-7","article-title":"Activation of the plasma kallikrein\/kinin system on endothelial cell membranes","volume":"43","author":"Rojkjaer","year":"1999","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.jaci.2004.06.047_bib262","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1172\/JCI0215490","article-title":"The plasma kallikrein-kinin system counterbalances the renin-angiotensin system","volume":"109","author":"Schmaier","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.06.047_bib263","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0037-1614255","article-title":"The physiologic basis of assembly and activation of the plasma kallikrein\/kinin system","volume":"91","author":"Schmaier","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaci.2004.06.047_bib264","first-page":"129","article-title":"Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin","volume":"120","author":"Kleniewski","year":"1992","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib265","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1084\/jem.152.3.742","article-title":"Detection of active kallikrein in induced blister fluids of hereditary angioedema patients","volume":"152","author":"Curd","year":"1980","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib266","first-page":"52","article-title":"Dose-dependent effects of postmenopausal estrogen and progestin on antithrombin III and factor XII","volume":"111","author":"Gordon","year":"1988","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib267","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1055\/s-0038-1657871","article-title":"Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen\u2014levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivator","volume":"54","author":"Jespersen","year":"1985","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaci.2004.06.047_bib268","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1210\/endo.136.11.7588244","article-title":"Molecular basis of estrogen regulation of Hageman factor XII gene expression","volume":"136","author":"Farsetti","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.jaci.2004.06.047_bib269","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0049-3848(94)90268-2","article-title":"Contact factors in plasma from women on oral contraception\u2014significance of factor XI for the measured activity of factor XII","volume":"74","author":"Fossum","year":"1994","journal-title":"Thromb Res"},{"key":"10.1016\/j.jaci.2004.06.047_bib270","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1146\/annurev.pa.32.040192.002455","article-title":"Biochemical and molecular pharmacology of kinin receptors","volume":"32","author":"Farmer","year":"1992","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.jaci.2004.06.047_bib271","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1074\/jbc.273.5.2784","article-title":"Transcription factor nuclear factor kappaB regulates the inducible expression of the human B1 receptor gene in inflammation","volume":"273","author":"Ni","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2004.06.047_bib272","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0162-3109(96)00077-X","article-title":"Receptors for kinins: from classical pharmacology to molecular biology","volume":"33","author":"Regoli","year":"1996","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.jaci.2004.06.047_bib273","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jcp.10175","article-title":"Mechanisms regulating the expression, self-maintenance, and signaling-function of the bradykinin B2 and B1 receptors","volume":"193","author":"Prado","year":"2002","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jaci.2004.06.047_bib274","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/sj.bjp.0701255","article-title":"Regulation of bradykinin B2-receptor expression by oestrogen","volume":"121","author":"Madeddu","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jaci.2004.06.047_bib275","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/pgmj.74.867.41","article-title":"Coexistence of hereditary angioedema and Turner's syndrome","volume":"74","author":"Fletcher","year":"1998","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jaci.2004.06.047_bib276","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00000441-200009000-00014","article-title":"Hereditary angioedema precipitated by estrogen replacement therapy in a menopausal woman","volume":"320","author":"McGlinchey","year":"2000","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jaci.2004.06.047_bib277","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0002-9343(02)01526-7","article-title":"Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy","volume":"114","author":"Bork","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib277a","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1365-2133.1986.tb06656.x","article-title":"Recurrent angioedema: familial and oestrogen-induced","volume":"115","author":"Warin","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2004.06.047_bib278","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000068456","article-title":"Angioedema and oral contraception","volume":"206","author":"Bouillet","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.jaci.2004.06.047_bib279","first-page":"301","article-title":"Recurrent angioedema associated with hypogonadism or anti-androgen therapy","volume":"63","author":"Pichler","year":"1989","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaci.2004.06.047_bib280","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0039-128X(96)00037-2","article-title":"Estrogen induction and contact phase activation of human factor XII","volume":"61","author":"Citarella","year":"1996","journal-title":"Steroids"},{"key":"10.1016\/j.jaci.2004.06.047_bib281","first-page":"353","article-title":"Enhanced expression of factor XII (Hageman factor) in isolated livers of estrogen- and prolactin-treated rats","volume":"117","author":"Gordon","year":"1991","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib282","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1182\/blood.V66.3.602.602","article-title":"The influence of estrogen and prolactin on Hageman factor (factor XII) titer in ovariectomized and hypophysectomized rats","volume":"66","author":"Gordon","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2004.06.047_bib283","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0167-4781(92)90069-C","article-title":"Differential regulation of kininogen gene expression by estrogen and progesterone in vivo","volume":"1131","author":"Chen","year":"1992","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jaci.2004.06.047_bib284","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1471-0528.1996.tb09716.x","article-title":"The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives","volume":"103","author":"Norris","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jaci.2004.06.047_bib285","first-page":"1231","article-title":"Effects of a very low-estrogen oral contraceptive on clotting factors, carbohydrate metabolism and plasma lipids and lipoproteins","volume":"15","author":"Thiery","year":"1987","journal-title":"Med Sci Res"},{"key":"10.1016\/j.jaci.2004.06.047_bib286","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0049-3848(91)90343-U","article-title":"Contact activation factors in plasma from women using oral contraceptives\u2014increased levels of factor XII, kinin-free high molecular weight kininogen and acetone-activated kallikrein","volume":"64","author":"Hoem","year":"1991","journal-title":"Thromb Res"},{"key":"10.1016\/j.jaci.2004.06.047_bib287","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/1047-2797(92)90093-6","article-title":"Estrogen-associated thromboembolism","volume":"2","author":"Wessler","year":"1992","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.jaci.2004.06.047_bib288","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1471-0528.1993.tb12956.x","article-title":"Contact factor mediated fibrinolysis is increased by the combined oral contraceptive pill","volume":"100","author":"Campbell","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jaci.2004.06.047_bib289","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1210\/jcem.86.8.7768","article-title":"Prospective randomized study of effects of unopposed estrogen replacement therapy on markers of coagulation and inflammation in postmenopausal women","volume":"86","author":"Luyer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaci.2004.06.047_bib290","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1046\/j.1538-7836.2003.00362.x","article-title":"Positive impact of hormone replacement therapy on the fibrinolytic system: a long-term randomized controlled study in healthy postmenopausal women","volume":"1","author":"Madsen","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jaci.2004.06.047_bib291","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1161\/01.ATV.20.5.1404","article-title":"Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis","volume":"20","author":"Teede","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jaci.2004.06.047_bib292","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00042192-200105000-00011","article-title":"Effect of long-term hormone replacement therapy on angiotensin-converting enzyme activity and bradykinin in postmenopausal women with essential hypertension and normotensive postmenopausal women","volume":"8","author":"Nogawa","year":"2001","journal-title":"Menopause"},{"key":"10.1016\/j.jaci.2004.06.047_bib293","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/01.HYP.33.1.323","article-title":"Estrogen regulation of angiotensin-converting enzyme mRNA","volume":"33","author":"Gallagher","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.jaci.2004.06.047_bib294","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1365-2265.2004.02009.x","article-title":"Sex hormones in hereditary angioneurotic oedema","volume":"60","author":"Visy","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jaci.2004.06.047_bib295","series-title":"The complete drug reference","year":"1999"},{"key":"10.1016\/j.jaci.2004.06.047_bib296","series-title":"AHFS drug information 2000","year":"2000"},{"key":"10.1016\/j.jaci.2004.06.047_bib297","series-title":"DRUGDEX\u00ae system","year":"2001"},{"key":"10.1016\/j.jaci.2004.06.047_bib298","unstructured":"Reference deleted in proof"},{"key":"10.1016\/j.jaci.2004.06.047_bib299","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000247874","article-title":"Hereditary angioedema and oral contraception","volume":"181","author":"Borradori","year":"1990","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaci.2004.06.047_bib300","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/clinchem\/36.5.737","article-title":"Effects of methylamine and heparin on a rapid chromogenic assay of C1-esterase inhibitor in plasma","volume":"36","author":"Munkvad","year":"1990","journal-title":"Clin Chem"},{"key":"10.1016\/j.jaci.2004.06.047_bib301","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0022-1759(94)90303-4","article-title":"Effect of time, temperature and additives on a functional assay of C1 inhibitor","volume":"173","author":"Nielsen","year":"1994","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jaci.2004.06.047_bib302","unstructured":"Reference deleted in proof"},{"key":"10.1016\/j.jaci.2004.06.047_bib303","unstructured":"Reference deleted in proof"},{"key":"10.1016\/j.jaci.2004.06.047_bib304","unstructured":"Reference deleted in proof"},{"key":"10.1016\/j.jaci.2004.06.047_bib305","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/01.CIR.95.1.39","article-title":"Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women","volume":"95","author":"Schunkert","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jaci.2004.06.047_bib306","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1046\/j.1365-2133.2001.04175.x","article-title":"Management and diagnostic guidelines for urticaria and angio-oedema","volume":"144","author":"Grattan","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2004.06.047_bib307","first-page":"209","article-title":"Hereditary angioneurotic oedema in three families: symptomatic heterogeneity, complement analysis and therapeutic trials","volume":"191","author":"Blohme","year":"1972","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.jaci.2004.06.047_bib308","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.0954-6820.1977.tb15724.x","article-title":"Hereditary angioneurotic oedema in Finland: clinical, immunological and genealogical studies","volume":"201","author":"Ohela","year":"1977","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.jaci.2004.06.047_bib309","first-page":"143","article-title":"Hereditary angioedema due to deficit of C1 esterase inhibitor","volume":"27","author":"Zeana","year":"1989","journal-title":"Med Interne"},{"key":"10.1016\/j.jaci.2004.06.047_bib310","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1542\/peds.37.6.1017","article-title":"Hereditary angioneurotic edema: a clinical survey","volume":"37","author":"Donaldson","year":"1966","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2004.06.047_bib311","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/08820139109050781","article-title":"C1-INH defect as an example of deficiency disease","volume":"20","author":"Madalinski","year":"1991","journal-title":"Immunol Invest"},{"key":"10.1016\/j.jaci.2004.06.047_bib312","first-page":"931","article-title":"Hereditary angioedema: danazol therapy in a 5-year-old child","volume":"147","author":"Barakat","year":"1993","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.jaci.2004.06.047_bib313","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2044.1995.tb06050.x","article-title":"Hereditary angioneurotic oedema: current management in pregnancy","volume":"50","author":"Cox","year":"1995","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jaci.2004.06.047_bib314","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/jcp.55.2.145","article-title":"A multicentre evaluation of the diagnostic efficiency of serological investigations for C1 inhibitor deficiency","volume":"55","author":"Gompels","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jaci.2004.06.047_bib315","first-page":"1238","article-title":"[Hereditary angioedema: description of a sibship and review]","volume":"111","author":"Matter","year":"1981","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1016\/j.jaci.2004.06.047_bib316","series-title":"The complement system","first-page":"353","article-title":"Inherited and acquired deficiencies of C1 esterase inhibitor in humans","author":"Sp\u00e4th","year":"1998"},{"key":"10.1016\/j.jaci.2004.06.047_bib317","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-3083.1995.tb03711.x","article-title":"C3 is activated in hereditary angioedema, and C1\/C1-inhibitor complexes rise during physical stress in untreated patients","volume":"42","author":"Nielsen","year":"1995","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib318","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0049-3848(97)00136-9","article-title":"Contact system in healthy term newborns: reference values in cord blood","volume":"87","author":"Sonntag","year":"1997","journal-title":"Thromb Res"},{"key":"10.1016\/j.jaci.2004.06.047_bib319","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0022-1759(93)90240-8","article-title":"Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway","volume":"163","author":"Wolbink","year":"1993","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jaci.2004.06.047_bib320","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1203\/00006450-199402000-00012","article-title":"C1 inhibitor and diagnosis of hereditary angioedema in newborns","volume":"35","author":"Nielsen","year":"1994","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jaci.2004.06.047_bib321","first-page":"29","article-title":"[Determination of complement proteins in the umbilical cord in the early diagnosis of hereditary angioneurotic edema]","volume":"82","author":"Ferlazzo","year":"1991","journal-title":"Recenti Prog Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib322","first-page":"147","article-title":"Complement components in 100 newborns and their mothers determined by electroimmunoassay","volume":"91","author":"Johnson","year":"1983","journal-title":"Acta Pathol Microbiol Immunol Scand [C]"},{"key":"10.1016\/j.jaci.2004.06.047_bib323","first-page":"513","article-title":"Angioedema: a review on the acquired, allergic or non-allergic, and the hereditary forms","volume":"81","author":"Spath","year":"1990","journal-title":"Recenti Prog Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib324","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1203\/00006450-197909000-00019","article-title":"Serum complement levels in infancy: age related changes","volume":"13","author":"Davis","year":"1979","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jaci.2004.06.047_bib325","first-page":"1668","article-title":"[Complement fractions in cord blood: value for the neonatal detection of hereditary angioneurotic edema]","volume":"14","author":"Intrator","year":"1985","journal-title":"Presse Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib326","first-page":"918","article-title":"Influence of age and sex on serum complement components in children","volume":"135","author":"Roach","year":"1981","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.jaci.2004.06.047_bib327","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood.V70.1.165.165","article-title":"Development of the human coagulation system in the full-term infant","volume":"70","author":"Andrew","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2004.06.047_bib328","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3181\/00379727-173-41676","article-title":"Plasma protease inhibitors in premature infants: influence of gestational age, postnatal age, and health status","volume":"173","author":"Andrew","year":"1983","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib329","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0022-3476(75)80904-8","article-title":"Serum complement profiles in infants and children","volume":"87","author":"Norman","year":"1975","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2004.06.047_bib330","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1046\/j.1365-2133.2003.05231.x","article-title":"Misdiagnosis of hereditary angio-oedema type 1 and type 2","volume":"148","author":"Gompels","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2004.06.047_bib331","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/0091-6749(91)90248-M","article-title":"Acute consumption of C1 inhibitor in a patient with acquired C1-inhibitor deficiency syndrome","volume":"88","author":"Zuraw","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib332","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/jcp.2003.12021","article-title":"Normal complement C4 values do not exclude hereditary angioedema","volume":"57","author":"Karim","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jaci.2004.06.047_bib333","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0140-6736(73)92519-1","article-title":"Hereditary angioneurotic oedema","volume":"2","author":"Brackertz","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2004.06.047_bib334","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1056\/NEJM199606203342503","article-title":"Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate","volume":"334","author":"Waytes","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib335","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJM198003063021002","article-title":"Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor","volume":"302","author":"Gadek","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib336","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1398-9995.1983.tb01590.x","article-title":"C1 INH concentrate in the therapy of hereditary angioedema","volume":"38","author":"Bergamaschini","year":"1983","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2004.06.047_bib337","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1081-1206(10)63067-0","article-title":"C1-esterase inhibitor transfusions in patients with hereditary angioedema","volume":"80","author":"Visentin","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib338","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0140-6736(69)91295-1","article-title":"Replacement therapy in hereditary angioedema: successful treatment of two patients with fresh frozen plasma","volume":"1","author":"Pickering","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2004.06.047_bib339","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0161-5890(01)00040-2","article-title":"C1-inhibitor deficiency and angioedema","volume":"38","author":"Carugati","year":"2001","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib340","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/BF01489716","article-title":"Treatment of hereditary angioedema","volume":"56","author":"Marasini","year":"1978","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.jaci.2004.06.047_bib341","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0140-6736(76)93012-9","article-title":"Letter: anaphylactic reaction to aprotinin","volume":"2","author":"Proud","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2004.06.047_bib342","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1473-0502(03)00170-8","article-title":"DX-88 and HAE: a developmental perspective","volume":"29","author":"Williams","year":"2003","journal-title":"Transfus Apheresis Sci"},{"key":"10.1016\/j.jaci.2004.06.047_bib343","first-page":"1318","article-title":"The synthetic Kunitz domain protein DX-88 to treat angioedema in patients with hereditary angioedema","volume":"2","author":"Gonzales-Quevado","year":"2002","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaci.2004.06.047_bib344","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1067\/mai.2001.111145","article-title":"Role of kinins in seasonal allergic rhinitis: icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen","volume":"107","author":"Turner","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib345","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0162-3109(96)00065-3","article-title":"Efficacy and tolerability of Icatibant (Hoe 140) in patients with moderately severe chronic bronchial asthma","volume":"33","author":"Akbary","year":"1996","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.jaci.2004.06.047_bib345a","unstructured":"Jerini announces positive phase II study results with Icatibant for the treatment of Hereditary Angioedema [press release]. Berlin: Jerini Pharmaceuticals; January 13, 2004"},{"key":"10.1016\/j.jaci.2004.06.047_bib346","first-page":"1315","article-title":"A phase I study of recombinant human C1-INH in asymptomatic patients with hereditary angioedema-HAE","volume":"2","author":"Nuijens","year":"2002","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaci.2004.06.047_bib346a","unstructured":"Pharming features clinical results of C1 inhibitor at investigator meeting [press release]. Leiden: Pharming; January 19, 2004"},{"key":"10.1016\/j.jaci.2004.06.047_bib347","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJM197612232952602","article-title":"Treatment of hereditary angioedema with danazol: reversal of clinical and biochemical abnormalities","volume":"295","author":"Gelfand","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib348","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0091-6749(83)90034-9","article-title":"Morphologic evaluation of the liver in hereditary angioedema patients on long-term treatment with androgen derivatives","volume":"72","author":"Cicardi","year":"1983","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib349","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0091-6749(97)70095-2","article-title":"Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients","volume":"99","author":"Cicardi","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib350","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0015-0282(16)53638-3","article-title":"The long-term safety of danazol in women with hereditary angioedema","volume":"54","author":"Zurlo","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jaci.2004.06.047_bib351","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/0091-6749(91)90120-D","article-title":"Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience","volume":"87","author":"Cicardi","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib352","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0168-8278(98)80140-2","article-title":"Danazol therapy: an unusual aetiology of hepatocellular carcinoma","volume":"29","author":"Crampon","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.jaci.2004.06.047_bib353","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(99)00110-5","article-title":"Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema","volume":"353","author":"Bork","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2004.06.047_bib354","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0168-8278(02)00035-1","article-title":"Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema","volume":"36","author":"Bork","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jaci.2004.06.047_bib355","first-page":"733","article-title":"A case of hereditary angioneurotic oedema, successfully treated with epsilon-aminocaproic acid: studies on C'1 esterase inhibitor, C'1 activation, plasminogen level and histamine metabolism","volume":"3","author":"Lundh","year":"1968","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib356","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0091-6749(89)90082-1","article-title":"Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency","volume":"83","author":"Bork","year":"1989","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib357","first-page":"574","article-title":"Pharmacokinetic parameters of C1-inhibitor concentrate in 40 patients with hereditary angio-oedema (HAE)\u2014a prospective study","volume":"8","author":"Martinez-Saguer","year":"2002","journal-title":"Haemophilia"},{"key":"10.1016\/j.jaci.2004.06.047_bib358","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0278-2391(85)80014-8","article-title":"Acute airway obstruction following tooth extraction in hereditary angioedema","volume":"43","author":"Degroote","year":"1985","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jaci.2004.06.047_bib359","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0714.1991.tb00908.x","article-title":"Oral manifestations and dental management of patients with hereditary angioedema","volume":"20","author":"Atkinson","year":"1991","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib360","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1754-4505.1989.tb01016.x","article-title":"Hereditary angioedema: report of case","volume":"9","author":"Phillips","year":"1989","journal-title":"Spec Care Dentist"},{"key":"10.1016\/j.jaci.2004.06.047_bib361","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0091-6749(74)90109-2","article-title":"Prophylactic use of epsilon aminocaproic acid for oral surgery in a patient with hereditary angioneurotic edema","volume":"53","author":"Pence","year":"1974","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib362","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0091-6749(77)90080-X","article-title":"Tranexamic acid: preoperative prophylactic therapy for patients with hereditary angioneurotic edema","volume":"60","author":"Sheffer","year":"1977","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib363","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0266-4356(87)90143-4","article-title":"Intravenous tranexamic acid in the management of hereditary angio-oedema","volume":"25","author":"Crosher","year":"1987","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.jaci.2004.06.047_bib364","first-page":"1096","article-title":"Potentially fatal hereditary angioedema: a review and case report","volume":"56","author":"Hardie","year":"1990","journal-title":"J Can Dent Assoc"},{"key":"10.1016\/j.jaci.2004.06.047_bib365","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0278-2391(99)90280-X","article-title":"The efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental procedures","volume":"57","author":"Farkas","year":"1999","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jaci.2004.06.047_bib366","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/jcan.2002.125132","article-title":"Successful off-pump coronary artery bypass graft surgery in a patient with hereditary angioedema","volume":"16","author":"Lehmann","year":"2002","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jaci.2004.06.047_bib367","first-page":"169","article-title":"Preoperative prophylaxis for C1 esterase-inhibitor deficiency in patients undergoing oral surgery: a report of three cases","volume":"28","author":"Peled","year":"1997","journal-title":"Quintessence Int"},{"key":"10.1016\/j.jaci.2004.06.047_bib368","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000236506","article-title":"Hereditary angioedema: uncomplicated maxillofacial surgery using short-term C1 inhibitor replacement therapy","volume":"101","author":"Leimgruber","year":"1993","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib369","doi-asserted-by":"crossref","first-page":"383","DOI":"10.5694\/j.1326-5377.1994.tb138252.x","article-title":"C1-esterase inhibitor concentrate prevents upper airway obstruction in hereditary angio-oedema","volume":"160","author":"Langton","year":"1994","journal-title":"Med J Aust"},{"key":"10.1016\/j.jaci.2004.06.047_bib370","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1002\/1097-0142(19931201)72:11<3318::AID-CNCR2820721130>3.0.CO;2-N","article-title":"Acquired angioedema as the presenting feature of lymphoproliferative disorders of mature B-lymphocytes","volume":"72","author":"Bain","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.jaci.2004.06.047_bib371","first-page":"640","article-title":"[Acquired angioneurotic edema: clinical and biological characteristics in 9 patients]","volume":"29","author":"Bouillet","year":"2000","journal-title":"Presse Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib372","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/jcp.55.10.789","article-title":"Spontaneous regression of acquired C1 esterase inhibitor deficiency associated with splenic marginal zone lymphoma presenting with recurrent angio-oedema","volume":"55","author":"Phanish","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jaci.2004.06.047_bib373","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0091-6749(78)90210-5","article-title":"Acquired angioedema associated with rectal carcinoma and its response to danazol therapy: acquired angioedema treated with danazol","volume":"62","author":"Cohen","year":"1978","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib374","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/0091-6749(94)90380-8","article-title":"Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: a rationale for prophylactic use of tranexamic acid","volume":"93","author":"Cugno","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib375","first-page":"397","article-title":"Angioneurotic edema with acquired C1-inhibitor deficiency and autoantibody to C1-inhibitor: response to plasmapheresis and cytotoxic therapy","volume":"119","author":"Donaldson","year":"1992","journal-title":"J Lab Clin Med"},{"issue":"suppl 1","key":"10.1016\/j.jaci.2004.06.047_bib376","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/s-2002-30200","article-title":"Purity, activity, and virus safety of a pasteurized antithrombin concentrate","volume":"28","author":"Gr\u00f6ner","year":"2002","journal-title":"Semin Thromb Hemost"},{"issue":"suppl 1","key":"10.1016\/j.jaci.2004.06.047_bib377","first-page":"204","article-title":"A factor VIII concentrate, highly purified and heated in solution","volume":"10","author":"Heimburger","year":"1981","journal-title":"Haemostasis"},{"key":"10.1016\/j.jaci.2004.06.047_bib378","doi-asserted-by":"crossref","first-page":"35S","DOI":"10.1016\/0955-3886(90)90080-3","article-title":"Virus-safe plasma proteins: elimination of viruses of risk by the manufacturing procedure","volume":"11","author":"Hilfenhaus","year":"1990","journal-title":"Transf Sci"},{"issue":"suppl 1","key":"10.1016\/j.jaci.2004.06.047_bib379","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1423-0410.1994.tb00980.x","article-title":"Inactivation of hepatitis A virus by pasteurization and elimination of picornaviruses during manufacture of factor VIII concentrate","volume":"67","author":"Hilfenhaus","year":"1994","journal-title":"Vox Sang"},{"key":"10.1016\/j.jaci.2004.06.047_bib380","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM198910263211702","article-title":"Absence of anti-human immunodeficiency virus types 1 and 2 seroconversion after the treatment of hemophilia A or von Willebrand's disease with pasteurized factor VIII concentrate","volume":"321","author":"Schimpf","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib381","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJM198704093161505","article-title":"Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions","volume":"316","author":"Schimpf","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib382","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0049-3848(02)00044-0","article-title":"Effectiveness of alternative treatments for reducing potential viral contaminants from plasma-derived products","volume":"105","author":"Chandra","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.jaci.2004.06.047_bib383","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1046\/j.1537-2995.2002.00158.x","article-title":"Inactivation of parvovirus B19 during pasteurization of human serum albumin","volume":"42","author":"Bl\u00fcmel","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.jaci.2004.06.047_bib384","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa030781","article-title":"A novel coronavirus associated with severe acute respiratory syndrome","volume":"348","author":"Ksiazek","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib385","first-page":"824","article-title":"Virus safety of pasteurized clotting factor concentrates: an eleven year follow up","volume":"65","author":"Kreuz","year":"1991","journal-title":"Thromb Hemost"},{"key":"10.1016\/j.jaci.2004.06.047_bib386","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1537-2995.1996.36196190522.x","article-title":"Hepatitis C and pasteurized C1-inhibitor concentrate","volume":"36","author":"Klarmann","year":"1996","journal-title":"Transfusion"},{"key":"10.1016\/j.jaci.2004.06.047_bib387","first-page":"59","article-title":"Prospective virus safety follow-up after therapy with a pasteurized C1-inhibitor concentrate","volume":"5","author":"Bork","year":"1992","journal-title":"Biomed Prog"},{"key":"10.1016\/j.jaci.2004.06.047_bib388","first-page":"2339","article-title":"Prophylactic treatment with pasteurised C1 inhibitor in herditary angioedema (HAE)\u2014a prospective 32 months follow up","volume":"94","author":"Martinez-Saguer","year":"1999","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1016\/j.jaci.2004.06.047_bib389","first-page":"S73","article-title":"Prospective follow up of clinical manifestation and therapy in children with hereditary angioedema (HAE)","volume":"82","author":"Rusicke","year":"2003","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jaci.2004.06.047_bib390","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1046\/j.1537-2995.2001.41121500.x","article-title":"High-titer screening PCR: a successful strategy for reducing the parvovirus B19 load in plasma pools for fractionation","volume":"41","author":"Weimer","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.jaci.2004.06.047_bib391","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1365-2249.2003.02199.x","article-title":"Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulin","volume":"133","author":"Brennan","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib392","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2165\/00128072-200204030-00002","article-title":"State of care for hemophilia in pediatric patients","volume":"4","author":"Santagostino","year":"2002","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jaci.2004.06.047_bib393","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1056\/NEJM199606203342510","article-title":"Hereditary angioedema","volume":"334","author":"Cicardi","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib394","first-page":"299","article-title":"Treatment of acute attacks of hereditary angioedema with C1-inhibitor concentrate","volume":"44","author":"Agostoni","year":"1980","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaci.2004.06.047_bib395","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/archinte.163.10.1229","article-title":"Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency","volume":"163","author":"Bork","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib396","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1172\/JCI114185","article-title":"Proteolytic inactivation of plasma C1- inhibitor in sepsis","volume":"84","author":"Nuijens","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.06.047_bib397","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1006\/prep.2001.1445","article-title":"Expression of active human C1 inhibitor serpin domain in Escherichia coli","volume":"22","author":"Lamark","year":"2001","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.jaci.2004.06.047_bib398","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/glycob\/cwh010","article-title":"N- and O-glycans of recombinant human C1 Inhibitor expressed in the milk of transgenic rabbits","volume":"14","author":"Koles","year":"2004","journal-title":"Glycobiology"},{"key":"10.1016\/j.jaci.2004.06.047_bib399","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1126\/science.1088166","article-title":"Production of complex human glycoproteins in yeast","volume":"301","author":"Hamilton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jaci.2004.06.047_bib400","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1570-9639(03)00107-9","article-title":"Recombinant human C1-inhibitor produced in Pichia pastoris has the same inhibitory capacity as plasma C1-inhibitor","volume":"1648","author":"Bos","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jaci.2004.06.047_bib401","first-page":"34","article-title":"Recombinant human C1-inhibitor produced in Pichia pastoris has the same inhibitory capacity as plasma C1-inhibitor","volume":"3","author":"Hack","year":"2003","journal-title":"Abstracts of the International C1-Esterase Deficiency Workshop"},{"key":"10.1016\/j.jaci.2004.06.047_bib402","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1172\/JCI116260","article-title":"Recombinant C1 inhibitor P5\/P3 variants display resistance to catalytic inactivation by stimulated neutrophils","volume":"91","author":"Eldering","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.06.047_bib403","first-page":"93","article-title":"The effect of danazol in the treatment of chronic cystic mastitis","volume":"48","author":"Lauersen","year":"1976","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaci.2004.06.047_bib404","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/00003081-198812000-00009","article-title":"Danazol-induced pseudomenopause in the management of endometriosis","volume":"31","author":"Dmowski","year":"1988","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jaci.2004.06.047_bib405","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0015-0282(16)46757-9","article-title":"Effects of danazol on pulsatile gonadotropin patterns and on serum estradiol levels in normally cycling women","volume":"39","author":"Dmowski","year":"1983","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jaci.2004.06.047_bib406","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0015-0282(16)60782-3","article-title":"Cortical and trabecular bone mineral content in women with endometriosis: effect of gonadotropin-releasing hormone agonist and danazol","volume":"52","author":"Dawood","year":"1989","journal-title":"Fertil Steril"},{"issue":"suppl 1","key":"10.1016\/j.jaci.2004.06.047_bib407","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000181335","article-title":"A comparison of the skeletal effects of goserelin and danazol in premenopausal women with endometriosis","volume":"32","author":"Stevenson","year":"1989","journal-title":"Horm Res"},{"key":"10.1016\/j.jaci.2004.06.047_bib408","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/09513599009024979","article-title":"Evidence of similar increases in bone turnover during nafarelin and danazol use in women with endometriosis","volume":"4","author":"Ylikorkala","year":"1990","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jaci.2004.06.047_bib409","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2265.1990.tb00501.x","article-title":"The effects of nafarelin and danazol on vertebral trabecular bone mass in patients with endometriosis","volume":"33","author":"Whitehouse","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jaci.2004.06.047_bib410","first-page":"198","article-title":"Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group","volume":"82","author":"Rock","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaci.2004.06.047_bib411","first-page":"410","article-title":"Bone mass in endometriosis patients treated with GnRH agonist implant or danazol","volume":"77","author":"Dodin","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaci.2004.06.047_bib412","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0015-0282(16)58685-3","article-title":"Excretion of urinary N-telopeptides reflects changes in bone turnover during ovarian suppression and indicates individually variable estradiol threshold for bone loss","volume":"66","author":"Dmowski","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jaci.2004.06.047_bib413","series-title":"The physiology of reproduction","first-page":"447","article-title":"Mechanism of mammalian ovulation","author":"Lipner","year":"1988"},{"key":"10.1016\/j.jaci.2004.06.047_bib414","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2249.1990.tb05453.x","article-title":"Complement, complement activation and anaphylatoxins in human ovarian follicular fluid","volume":"82","author":"Perricone","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib415","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2249.1992.tb05858.x","article-title":"Cystic ovaries in women affected with hereditary angioedema","volume":"90","author":"Perricone","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib416","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0162-3109(89)90061-1","article-title":"Increased plasma beta-endorphin levels in hereditary angioedema","volume":"18","author":"Perricone","year":"1989","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.jaci.2004.06.047_bib417","first-page":"630","article-title":"Elevated levels of plasma beta-endorphin and gamma 3-melanocyte stimulating hormone in the polycystic ovary syndrome","volume":"63","author":"Wortsman","year":"1984","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaci.2004.06.047_bib418","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1046\/j.1365-3083.2000.00652.x","article-title":"Impaired human ovarian follicular fluid complement function in hereditary angioedema","volume":"51","author":"Perricone","year":"2000","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib419","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2249.1992.tb06895.x","article-title":"Functionally active complement is present in human ovarian follicular fluid and can be activated by seminal plasma","volume":"89","author":"Perricone","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib420","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1055\/s-2008-1069374","article-title":"[Hereditary angioneurotic edema. Clinical picture, diagnosis, patient management and drug therapy]","volume":"109","author":"Bork","year":"1984","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.jaci.2004.06.047_bib421","series-title":"The complement system","first-page":"366","article-title":"Inherited and acquired deficiency of C1 esterase inhibitor in humans","author":"Spaeth","year":"1998"},{"key":"10.1016\/j.jaci.2004.06.047_bib422","first-page":"114","article-title":"[Hereditary angioedema in the German-speaking region]","volume":"49","author":"Goring","year":"1998","journal-title":"Hautarzt"},{"key":"10.1016\/j.jaci.2004.06.047_bib423","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1537-2995.1998.38398222877.x","article-title":"Transmission of hepatitis G virus in patients with angioedema treated with steam-heated plasma concentrates of C1 inhibitor","volume":"38","author":"De Filippi","year":"1998","journal-title":"Transfusion"},{"key":"10.1016\/j.jaci.2004.06.047_bib424","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0091-6749(83)90280-4","article-title":"Loss of danazol responsiveness in angioedema with C1 inhibitor deficiency","volume":"71","author":"Purtell","year":"1983","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib425","series-title":"Experimental immunochemistry","first-page":"213","article-title":"Complement and complement fixation","author":"Mayer","year":"1962"},{"key":"10.1016\/j.jaci.2004.06.047_bib426","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.4049\/jimmunol.99.6.1211","article-title":"Immunochemical quantitation of the third, fourth and fifth components of human complement: concentrations in the serum of healthy adults","volume":"99","author":"Kohler","year":"1967","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib427","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/0016-5085(87)90576-2","article-title":"Recurrent abdominal pain as the sole manifestation of hereditary angioedema in multiple family members","volume":"93","author":"Weinstock","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2004.06.047_bib428","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(05)76637-X","article-title":"Danazol therapy for hereditary angio-oedema in children","volume":"354","author":"Farkas","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2004.06.047_bib429","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJM197204132861503","article-title":"Epsilon aminocaproic acid therapy of hereditary angioneurotic edema: a double-blind study","volume":"286","author":"Frank","year":"1972","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib430","first-page":"1317","article-title":"Danazol for children with immune thrombocytopenic purpura","volume":"142","author":"Weinblatt","year":"1988","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.jaci.2004.06.047_bib431","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/pai.1996.10.155","article-title":"Hereditary angio-oedema in children","volume":"10","author":"Lakshminrusimha","year":"1996","journal-title":"Pediatr Asthma Allergy Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib432","first-page":"435","article-title":"Tonsillectomy in a patient with hereditary angioedema after prophylaxis with C1 inhibitor concentrate","volume":"73","author":"Maves","year":"1994","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaci.2004.06.047_bib433","first-page":"2471","article-title":"[Hereditary angioneurotic edema, analysis of 3 cases]","volume":"113","author":"Raffai","year":"1972","journal-title":"Orv Hetil"},{"key":"10.1016\/j.jaci.2004.06.047_bib434","doi-asserted-by":"crossref","first-page":"9622","DOI":"10.1073\/pnas.91.20.9622","article-title":"A cluster of mutations within a short triplet repeat in the C1 inhibitor gene","volume":"91","author":"Bissler","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2004.06.047_bib435","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.1073\/pnas.87.17.6786","article-title":"Dysfunctional C1 inhibitor Ta: deletion of Lys-251 results in acquisition of an N-glycosylation site","volume":"87","author":"Parad","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2004.06.047_bib436","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000154267","article-title":"Characterisation of nucleotide sequence variants and disease-specific mutations involving the 3\u2032 end of the C1-inhibitor gene in hereditary angio-oedema","volume":"45","author":"Siddique","year":"1995","journal-title":"Hum Hered"},{"key":"10.1016\/j.jaci.2004.06.047_bib437","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF00206079","article-title":"An RNA splice site mutation in the C1-inhibitor gene causes type I hereditary angio-oedema","volume":"88","author":"Siddique","year":"1991","journal-title":"Hum Genet"},{"key":"10.1016\/j.jaci.2004.06.047_bib438","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s004390050238","article-title":"A point mutation in exon 7 of the C1-inhibitor gene causing type I hereditary angioedema","volume":"98","author":"Ono","year":"1996","journal-title":"Hum Genet"},{"key":"10.1016\/j.jaci.2004.06.047_bib439","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1046\/j.1523-1747.1998.00170.x","article-title":"A novel donor splice site mutation in the C1 inhibitor gene of a patient with type I hereditary angioneurotic edema","volume":"110","author":"Kawachi","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2004.06.047_bib440","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1172\/JCI115373","article-title":"Nonsense mutations affect C1 inhibitor messenger RNA levels in patients with type I hereditary angioneurotic edema","volume":"88","author":"Frangi","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.06.047_bib441","first-page":"664","article-title":"[Identification of a novel mutation of C1 inhibitor gene in a Chinese family with hereditary angioedema]","volume":"25","author":"Zhi","year":"2003","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"10.1016\/j.jaci.2004.06.047_bib442","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000154075","article-title":"A single base deletion from the C1-inhibitor gene causes type I hereditary angio-oedema","volume":"42","author":"Siddique","year":"1992","journal-title":"Hum Hered"},{"key":"10.1016\/j.jaci.2004.06.047_bib443","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF00219690","article-title":"C1-inhibitor gene nucleotide insertion causes type II hereditary angio-oedema","volume":"92","author":"Siddique","year":"1993","journal-title":"Hum Genet"},{"key":"10.1016\/j.jaci.2004.06.047_bib444","doi-asserted-by":"crossref","first-page":"9216","DOI":"10.1016\/S0021-9258(18)31573-4","article-title":"Substrate properties of C1 inhibitor Ma (alanine 434-glutamic acid): genetic and structural evidence suggesting that the P12-region contains critical determinants of serine protease inhibitor\/substrate status","volume":"266","author":"Skriver","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2004.06.047_bib445","first-page":"11","article-title":"Identification of type I hereditary angio-oedema (HAE) mutations","volume":"85S","author":"Siddique","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib446","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1073\/pnas.87.1.265","article-title":"Type II hereditary angioneurotic edema that may result from a single nucleotide change in the codon for alanine-436 in the C1 inhibitor gene","volume":"87","author":"Levy","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2004.06.047_bib447","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0014-5793(92)80204-T","article-title":"A dysfunctional C1 inhibitor protein with a new reactive center mutation (Arg-444-Leu)","volume":"301","author":"Frangi","year":"1992","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jaci.2004.06.047_bib448","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000154086","article-title":"Type II hereditary angio-oedema associated with two mutations in one allele of the C1-inhibitor gene around the reactive-site coding region","volume":"42","author":"Siddique","year":"1992","journal-title":"Hum Hered"},{"key":"10.1016\/j.jaci.2004.06.047_bib449","first-page":"330","article-title":"C1-inhibitors and their genes: an update","volume":"119","author":"Donaldson","year":"1992","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib450","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-3083.1998.00290.x","article-title":"Identification of a C\u2192T mutation in the reactive-site coding region of the C1-inhibitor gene and its detection by an improved mutation-specific polymerase chain reaction method","volume":"47","author":"Nielsen","year":"1998","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaci.2004.06.047_bib451","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0014-5793(90)81494-9","article-title":"Identification of a new P1 residue mutation (444Arg-Ser) in a dysfunctional C1 inhibitor protein contained in a type II hereditary angioedema plasma","volume":"266","author":"Aulak","year":"1990","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jaci.2004.06.047_bib452","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/BF03401610","article-title":"A mutation unique in serine protease inhibitors (serpins) identified in a family with type II hereditary angioneurotic edema","volume":"1","author":"Ocejo-Vinyals","year":"1995","journal-title":"Mol Med"},{"key":"10.1016\/j.jaci.2004.06.047_bib453","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/clin.1993.1156","article-title":"A de novo deletion in the C1 inhibitor gene in a case of sporadic hereditary angioneurotic edema","volume":"69","author":"Ariga","year":"1993","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.jaci.2004.06.047_bib454","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000154171","article-title":"A point mutation in the C1-inhibitor gene causes type I hereditary angiooedema","volume":"43","author":"Siddique","year":"1993","journal-title":"Hum Hered"},{"key":"10.1016\/j.jaci.2004.06.047_bib455","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1073\/pnas.87.4.1551","article-title":"Clusters of intragenic Alu repeats predispose the human C1 inhibitor locus to deleterious rearrangements","volume":"87","author":"Stoppa-Lyonnet","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2004.06.047_bib456","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1078\/0171-2985-00151","article-title":"Structural and functional aspects of C1-inhibitor","volume":"205","author":"Bos","year":"2002","journal-title":"Immunobiology"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674904017579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674904017579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:53:32Z","timestamp":1758776012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674904017579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":463,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0091674904017579"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2004.06.047","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2004.06.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}